International validation of a nomogram to predict recurrence after resection of grade 1 and 2 pancreatic neuroendocrine tumors
Charlotte M. Heidsma(Amsterdam University Medical Centers), E.J.M. Nieveen van Dijkum(Amsterdam University Medical Centers), Jaswinder S. Samra(The University of Sydney), Marc G. Besselink(Amsterdam Neuroscience), Susan van Dieren(Amphia Ziekenhuis), Simon Schimmack(Heidelberg University), Vikram Deshpande(Beth Israel Deaconess Medical Center), Frederik J.H. Hoogwater(University Medical Center Groningen), Stijn van Roessel(Amsterdam University Medical Centers), Casper H.J. van Eijck(Erasmus MC), Josefine Kjaer(Uppsala University), Marlinda Adham, Ammara Gill, Oliver Strobel(Medical University of Vienna), Olov Norlén(Uppsala University), Ankush Mittal(Indian Institute of Technology Roorkee), Julie Périnel(Hôpital Edouard Herriot), Anton F. Engelsman(The University of Sydney), Markus W. Buechler(Heidelberg University)
Cited by 0
Related Papers
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914